Matches in Wikidata for { <http://www.wikidata.org/entity/Q60922505> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q60922505 description "article by Carlo Sposito & Vincenzo Mazzaferro published December 2018 in Hepatobiliary surgery and nutrition" @default.
- Q60922505 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60922505 description "wetenschappelijk artikel" @default.
- Q60922505 description "наукова стаття, опублікована в грудні 2018" @default.
- Q60922505 name "The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future" @default.
- Q60922505 name "The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future" @default.
- Q60922505 type Item @default.
- Q60922505 label "The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future" @default.
- Q60922505 label "The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future" @default.
- Q60922505 prefLabel "The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future" @default.
- Q60922505 prefLabel "The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future" @default.
- Q60922505 P1433 Q60922505-741212AE-FE40-4E8E-B208-6CD1C0600350 @default.
- Q60922505 P1476 Q60922505-E4E4C854-C3B8-4DF7-8B83-568316B9AB08 @default.
- Q60922505 P2093 Q60922505-45B9F1C5-26B8-4EC0-9C91-47FFC9C761BC @default.
- Q60922505 P2093 Q60922505-4D895F82-6F33-4B28-83F4-0DF70018CB60 @default.
- Q60922505 P2860 Q60922505-0181EF3E-E81F-4DDA-9744-6DF46B7499E8 @default.
- Q60922505 P2860 Q60922505-15D7B41C-EE63-44C8-9F66-AECA3F6BD455 @default.
- Q60922505 P2860 Q60922505-178ADF07-9454-4E77-8060-0DA38DBBB1B9 @default.
- Q60922505 P2860 Q60922505-1CCFB2C8-17CF-4263-97C0-6E6B90D4E606 @default.
- Q60922505 P2860 Q60922505-2618F22B-650E-4B98-B837-D294AEB6136F @default.
- Q60922505 P2860 Q60922505-641A8DB3-E575-4C9B-A2FB-788E3682C769 @default.
- Q60922505 P2860 Q60922505-6B72C829-7A9C-424E-A00A-8FC690F8C861 @default.
- Q60922505 P2860 Q60922505-6BBC4F6C-F8AF-4E3D-AAFA-7AA147BAAFA3 @default.
- Q60922505 P2860 Q60922505-70E7F236-8F17-4D0C-82A1-4243ECE7B863 @default.
- Q60922505 P2860 Q60922505-7297F759-557B-4947-95EC-EABF020175E2 @default.
- Q60922505 P2860 Q60922505-848C9A76-5753-434D-BC6F-F99C9D09D7E1 @default.
- Q60922505 P2860 Q60922505-A85BCAB9-820D-4C10-B00B-ADA06F6B5C73 @default.
- Q60922505 P2860 Q60922505-C5C8478B-E14E-4A2A-A9F4-31DE75C56D59 @default.
- Q60922505 P2860 Q60922505-E6158BA5-B08C-4FF2-98F5-8952CEB3AC66 @default.
- Q60922505 P2860 Q60922505-FC0855FF-286A-4EE6-A992-EBB1B769774A @default.
- Q60922505 P304 Q60922505-7ECCBA4A-5F59-46D1-AED6-4535BC92E322 @default.
- Q60922505 P31 Q60922505-28bd5262-0d68-412a-b786-41b0d4e15d67 @default.
- Q60922505 P31 Q60922505-F024892E-7E8D-4A74-977A-B3542A6F5149 @default.
- Q60922505 P356 Q60922505-28ADF3E1-E867-4264-A76C-19191949D804 @default.
- Q60922505 P407 Q60922505-7B29F3B8-6C71-4556-B455-8C64D24B8078 @default.
- Q60922505 P433 Q60922505-6A36C515-658F-4816-BD6C-4478E692BEAC @default.
- Q60922505 P478 Q60922505-E4A72654-FC90-4140-B4C1-84B253AE8035 @default.
- Q60922505 P577 Q60922505-C7AC18B1-6AD8-4DC0-8298-6EFD994EE8CE @default.
- Q60922505 P698 Q60922505-FD77756E-4A4C-4751-9729-8398371B53ED @default.
- Q60922505 P921 Q60922505-874AFA81-C38A-46F3-A199-E6328C8B5103 @default.
- Q60922505 P932 Q60922505-55067156-D649-42E3-A89C-8F98D08DC21A @default.
- Q60922505 P356 HBSN.2018.10.06 @default.
- Q60922505 P698 30652096 @default.
- Q60922505 P1433 Q26842328 @default.
- Q60922505 P1476 "The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future" @default.
- Q60922505 P2093 "Carlo Sposito" @default.
- Q60922505 P2093 "Vincenzo Mazzaferro" @default.
- Q60922505 P2860 Q27861075 @default.
- Q60922505 P2860 Q29547903 @default.
- Q60922505 P2860 Q35004090 @default.
- Q60922505 P2860 Q37687824 @default.
- Q60922505 P2860 Q37850992 @default.
- Q60922505 P2860 Q39707145 @default.
- Q60922505 P2860 Q41923187 @default.
- Q60922505 P2860 Q44089673 @default.
- Q60922505 P2860 Q47376936 @default.
- Q60922505 P2860 Q50055781 @default.
- Q60922505 P2860 Q50535030 @default.
- Q60922505 P2860 Q52677129 @default.
- Q60922505 P2860 Q52698157 @default.
- Q60922505 P2860 Q57763422 @default.
- Q60922505 P2860 Q88301343 @default.
- Q60922505 P304 "487-489" @default.
- Q60922505 P31 Q13442814 @default.
- Q60922505 P31 Q871232 @default.
- Q60922505 P356 "10.21037/HBSN.2018.10.06" @default.
- Q60922505 P407 Q1860 @default.
- Q60922505 P433 "6" @default.
- Q60922505 P478 "7" @default.
- Q60922505 P577 "2018-12-01T00:00:00Z" @default.
- Q60922505 P698 "30652096" @default.
- Q60922505 P921 Q1148337 @default.
- Q60922505 P932 "6295389" @default.